Kevin Lee is the founder of Bicycle Therapeutics. Backed by Deep Track Capital, EcoR1 Capital, Fairmount. Based in Cambridge, United Kingdom.
Kevin Lee, Ph.D., MBA, is the Chief Executive Officer of Bicycle Therapeutics, a pharmaceutical company pioneering a new class of therapeutics using its proprietary bicyclic peptide technology. He joined Bicycle Therapeutics from Pfizer, where he was senior vice president and chief scientific officer of the Rare Disease Research Unit. Prior to Pfizer, Lee worked at GlaxoSmithKline and lectured at Warwick University Medical School. He also founded Cambridge Biotechnology and Neurosolutions.
Full founder directory · Investor directory · Company funding database · Fundraising library